VEEVA SYSTEMS INC (VEEV) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$262.06

From 52W high−15.03%

Volume5.97M

Market cap$42.13B

P/E (TTM)41.9x

P/S (TTM)12.2x

Div yield—

Key dataSep 18, 2026

Open

$262.06

From 52W high

−15.03%

Volume

5.97M

Market cap

$42.13B

ValuationView details →

P/E (Fwd)

26.9x

EV/EBITDA

25.5x

P/E (TTM)

41.9x

RSI (14)

55.5

MomentumView details →

1D Return

−1.34%

YTD Return

+17.54%

SummaryUpdated Jul 1, 2026

Veeva Systems Inc. (NYSE:VEEV) is a leading provider of cloud-based software solutions specifically designed for the global life sciences industry. Founded in 2007 and headquartered in Pleasanton, California, the company went public in 2013 and has established itself as the dominant technology platform serving pharmaceutical, biotechnology, and medical device companies worldwide. Veeva operates as a specialized software-as-a-service (SaaS) provider, focusing exclusively on the unique regulatory, compliance, and operational needs of life sciences organizations throughout their drug development and commercialization processes.

Ask drillr about VEEVA SYSTEMS INC →

ValuationView details →

P/E (Fwd)

26.9x

P/E (TTM)

41.9x

EV/EBITDA

25.5x

EV/Sales

10.1x

P/S (TTM)

12.2x

P/B (TTM)

5.7x

ProfitabilityView details →

Gross Margin

74.89%

Net Margin

29.34%

EBITDA Margin

39.72%

ROE (TTM)

13.66%

ROA (TTM)

11.20%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

+16.50%

EPS YoY

+24.70%

FCF YoY

+23.67%

Revenue CAGR 3Y

+14.03%

EPS CAGR 3Y

+20.91%

EBITDA YoY

+41.06%

MomentumView details →

1D Return

−1.34%

YTD Return

+17.54%

1Y Return

−5.55%

RSI (14)

55.5

vs 50D SMA

+12.00%

vs 200D SMA

+31.66%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

5.46x

Quick Ratio

5.46x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$2.35

EPS Surprise

5.38%

Beats (12Q)

11/12

Next Q EPS Est

$2.34

Avg Surprise (4Q)

−2.21%

Rev Surprise

2.49%

Financials snapshotView financials →

Revenue (TTM)

3.46B

Net Income (TTM)

1.01B

Op. CF (TTM)

1.67B

Next earningsNov 25, 2026 →

Latest newsMore news →

Amgen plans to implement Veeva Vault CRM globally, consolidating its collaboration with Veeva Systems.5d ago

The Trade Desk announced expanded healthcare measurement and optimization integrations with Veeva Crossix and IQVIA Digital for pharmaceutical advertisers.5d ago

Similar companies

BrightSpring Health Services, Inc. Tangible Equity UnitBTSGU XtalPi Holdings Ltd02228.HK BIT Computer Co., Ltd032850.KQ GE HealthCare Technologies Inc.GEHC Neurophet380550.KQ Tempus AI, Inc.TEM Find similar companies →

Latest newsMore news →

Amgen plans to implement Veeva Vault CRM globally, consolidating its collaboration with Veeva Systems.5d ago The Trade Desk announced expanded healthcare measurement and optimization integrations with Veeva Crossix and IQVIA Digital for pharmaceutical advertisers.5d ago